This inventor holds 16 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignees: Orexo Ab, Edenbridge Pharmaceuticals, LLC, Xspray Pharma Ab. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2026
Title: The Innovative Mind of Andreas Fischer
Introduction
Andreas Fischer, a distinguished inventor based in Uppsala, Sweden, has made significant contributions in the field of pharmaceuticals. With an impressive portfolio of 12 patents, Fischer is recognized for his work in developing innovative delivery systems for critical medications.
Latest Patents
Fischer's latest patents showcase his expertise in pharmaceutical compositions designed for nasal delivery. One of his notable inventions is a solid pharmaceutical composition formulation for nasal delivery of an opioid antagonist. This formulation includes a pharmacologically-effective amount of the antagonist and utilizes pharmaceutically-acceptable carriers such as disaccharides and dextrins. It is designed to be produced as a powder through spray-drying and is packaged in single-use nasal applicators for treating opioid overdoses.
Another important patent from Fischer focuses on a spray-dried powder composition suitable for transmucosal drug delivery, including both sublingual and nasal applications. This composition, too, maintains the use of preferred carriers like lactose and trehalose and is enhanced with alkyl saccharides, specifically sucrose esters, to improve efficacy in drug delivery systems.
Career Highlights
Andreas Fischer has established himself in the pharmaceutical industry through his innovative research and dedication to improving drug delivery methods. His work at Orexo AB exemplifies his commitment to addressing critical medical challenges through scientific advancement. His patents reflect a deep understanding of pharmacology and a desire to enhance patient outcomes through accessible treatment options.
Collaborations
Fischer has collaborated with notable colleagues such as Jonas Sävmarker and Robert Rönn, further amplifying the impact of his research. These partnerships have played a crucial role in the development and refinement of his inventions, fostering a collaborative environment ripe for innovation.
Conclusion
Through his groundbreaking inventions and collaborative efforts, Andreas Fischer continues to pave the way for advancements in pharmaceutical technology. His commitment to developing effective delivery systems is essential in addressing some of today's most pressing health crises. As the landscape of drug delivery continues to evolve, Fischer's contributions will undoubtedly leave a lasting mark in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile